Evidence map›Paper›PMID 31369213›Full record

ArticleCancer medicine2019

Multicenter study of carbon-ion radiation therapy for nonsquamous cell carcinomas of the oral cavity.

Hiroaki Ikawa, Masashi Koto, Yusuke Demizu, Jun-Ichi Saitoh, Hiroaki Suefuji, Tomoaki Okimoto, Tatsuya Ohno, Yoshiyuki Shioyama, Ryo Takagi, Kazuhiko Hayashi and 3 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Cancer medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Carbon-ion radiotherapy for clear cell odontogenic carcinomas.World journal of surgical oncology · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Hiroaki IkawaHospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology, Chiba, Japan.ORCID https://orcid.org/0000-0002-1081-1136
Masashi KotoHospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology, Chiba, Japan.
Yusuke DemizuDepartment of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Japan.
Jun-Ichi SaitohGunma University Heavy Ion Medical Center, Maebashi, Japan.
Hiroaki SuefujiIon Beam Therapy Center, SAGA-HIMAT Foundation, Tosu, Japan.ORCID https://orcid.org/0000-0002-1574-5510
Tomoaki OkimotoDepartment of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Japan.
Tatsuya OhnoGunma University Heavy Ion Medical Center, Maebashi, Japan.
Yoshiyuki ShioyamaIon Beam Therapy Center, SAGA-HIMAT Foundation, Tosu, Japan.
Ryo TakagiDepartment of Oral Pathobiological Science and Surgery, Tokyo Dental College, Tokyo, Japan.
Kazuhiko HayashiHospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology, Chiba, Japan.ORCID https://orcid.org/0000-0001-5054-4629
Kenji NemotoDepartment of Radiation Oncology, Faculty of Medicine, Yamagata University, Yamagata, Japan.
Takashi NakanoGunma University Heavy Ion Medical Center, Maebashi, Japan.
Tadashi KamadaHospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology, Chiba, Japan.
National Institutes for Quantum Science and Technology · JPGunma University Hospital · JPHyogo Ion Beam Medical Center · JPSAGA Heavy Ion Medical Accelerator in Tosu · JPTokyo Dental College · JPYamagata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to evaluate the efficacy and safety of carbon-ion radiation therapy for nonsquamous cell carcinomas of the oral cavity in a multicenter study.

methodsRetrospective analysis of the clinicopathological features and outcomes of 76 patients with oral nonsquamous cell carcinomas with N0-1 M0 status and were treated with carbon-ion radiation therapy at four institutions in Japan between November 2003 and December 2014 was performed.

resultsSalivary gland carcinoma, mucosal melanoma, and three other carcinomas were found in 46, 27, and 3 patients, respectively. T1-3, T4a, and T4b disease was diagnosed in 27, 18, and 31 patients, respectively. Median follow-up period was 31.1 months (range, 3-118 months). Three-year local control, progression-free survival, and overall survival of all patients were 86.8%, 63.1%, and 78.4%, respectively. Multivariate analysis showed T classification (T4) to be a significant independent poor prognostic factor for local control. Acute grade 3 mucositis was observed in 38 patients. Grades 3 and 4 late morbidities were observed in 9 and 4 patients, respectively. No grade 5 late toxicity was observed.

conclusionsOral nonsquamous cell carcinomas could be treated effectively, with acceptable toxicity, by carbon-ion radiation therapy.

Indexed as

AdultAgedAged, 80 and overCarcinomaFemaleHeavy Ion RadiotherapyHumansMaleMiddle AgedMouth NeoplasmsNeoplasm StagingRetrospective StudiesSurvival AnalysisTreatment Outcomeadenoid cystic carcinomacarbon-ion radiotherapyhead and neck canceroral cancerosteoradionecrosisparticle therapy

Identifiers

PMID31369213
PMCPMC6745861
OpenAlexW2966098405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.